scholarly journals Status Epilepticus During Recovery from General Anesthesia

2021 ◽  
pp. 1-3
Author(s):  
Bora Dinc ◽  
Ilker Onguc Aycan ◽  
Aslı Toylu

Propofol is an anesthetic agent commonly used for sedation and induction and/or maintenance of general anesthesia and presents an inhibitory effect on the excitatory neurotransmitters through GABA receptors. Although propofol is an agent that can be used to treat status epilepticus because of its anticonvulsant property, it may cause epileptiform convulsions, as reported in the literature. In this case report, a young patient’s epileptiform convulsions after administering a single dose of propofol injection for general anesthesia are presented. Due to uncontrolled epilepsy episodes following extubation, the patient was taken to intensive care. The patient regained consciousness, and epileptic attacks were controlled on the 4th day of intensive, was taken to the neurology service. We consider that this case is noteworthy concerning the association between propofol and epilepsy in anesthesia. Thus, this study aimed to draw attention to propofol in patients with a history of epilepsy.

2018 ◽  
Vol 25 (4) ◽  
pp. 618-621 ◽  
Author(s):  
Emilie Panicucci ◽  
Mikael Cohen ◽  
Veronique Bourg ◽  
Fanny Rocher ◽  
Pierre Thomas ◽  
...  

Background: Dalfampridine extended release (DAL) is a broad-spectrum voltage-gated potassium channel blocker that is indicated in multiple sclerosis to improve the nerve conduction of demyelinated axons. Seizures are a known side effect of DAL, which is contraindicated in patients with a history of epilepsy. Objective: Three cases of multiple sclerosis (MS) with de novo convulsive status epilepticus (CSE) probably related to dalfampridine administration are described. Methods: No patients had a history of seizures or renal impairment. Biological tests were normal. A brain magnetic resonance imaging (MRI) showed diffuse cortical and subcortical atrophy without active inflammatory lesions. Results: All three patients presented with CSE that was attributed to DAL and so was discontinued. Conclusion: These case reports illustrate that, aside from seizures, de novo CSE is a potential complication of MS patients treated with DAL.


1898 ◽  
Vol 44 (184) ◽  
pp. 169-173
Author(s):  
C. Hubert Bond

Sclerosis of the Cornu Ammonis in Epilepsy.—Dr. W. L. Worcester (Journ. Nerv. and Ment. Disease, April and May, 1897) details his experience as to the frequency with which this lesion is found when systematically searched for, and discusses its relation to the pathology of epilepsy. He prefaces his own observations by a summary of previous ones, dating from those of Meynert in 1868. From these it would appear that the preponderance of authority is in favour of the view that the lesion in question is a result rather than a cause of the convulsions observed during life. Worcester's experience is based upon the appearances presented by the brains of forty-three epileptics, which he examined at the Arkansas and Danvers Asylums. In only nineteen of these was there an absence of any gross cerebral lesion. The one under consideration, namely, sclerosis of the cornu ammonis, was present on one or both sides in twenty cases, in eleven of which no other abnormality was found; while in nine it was accompanied by other and more extensive lesions which he believed had a common origin with it; and this association appeared to him to throw light on the nature of the connection between it and convulsions. Of these associated abnormalities the most frequent he found to be microgyria of an entire hemisphere. The histological characters of the diseased cornu ammonis seemed to have been remarkably uniform, and consisted of a general sclerosis, involving destruction of the neurons having their origin in the stratum pyramidale and nucleus fasciæ dentatæ. Such a condition the writer failed to note in a series of over a hundred and fifty brains of insane patients, save in those of epileptics. Exception, however, must be made to this generalisation, for the case of a patient dying subsequently to the printing of this monograph. It was that of a general paralytic in whom there was no history of epilepsy, nor had he suffered at all from convulsions; yet after death changes were noted identical with those above described. Still, the frequency of this condition in epileptics and its great rarity in those not subject to this disease, would seem to place it beyond the pale of mere coincidence. The question is whether the epilepsy causes the anatomical changes or they the epilepsy. The chief reason why the former view is held by the majority appears to be due, rather to the improbability of this convolution, from anything that is known, having any special relation to epilepsy, than to any definite theory as to the way in which epilepsy could bring about such changes in a single convolution. The writer himself would rather lean to the supposition that the condition of the cornu ammonis is the cause of the convulsions. In support of this view, he cites the fact that it is known that a cicatrix of the cortex may act as a focus of irritation, and gives references of evidence proving that irritation of the temporal lobe may excite convulsions. He does not wish it to be understood that he believes in this convolution having any special prerogative in this respect, but rather that a scar in any part of the cortex may have such an effect. Neither, also, would he assert that all epilepsies originate in any part of the cerebral cortex, for the certainty that epileptiform convulsions may be due to peripheral irritations and to toxæmic conditions is too clear.


Author(s):  
Joseph Bruni ◽  
L. James Willmore

SUMMARY:The management of the pregnant epileptic requires close cooperation between the neurologist and obstetrician. To prevent complications, knowledge is required about the natural history of epilepsy during pregnancy, the possible teratogenic effects of antiepileptic drugs, and changes in their absorption, biotransformation, and excretion. Close plasma antiepileptic drug monitoring is required because of the change in the handling of antiepileptic drugs during pregnancy. The treatment of status epilepticus with intravenous phenytoin is effective. Drug interactions which may lead to toxic plasma levels of some drugs and subtherapeutic plasma levels of others should be anticipated. The risk of problems resulting from antiepileptic drug therapy during pregnancy appears to be minor, provided that proper medical supervision is available. Newer antiepileptic drugs should not be administered to the pregnant epileptic until their safety in pregnancy is fully established.


2016 ◽  
Vol 23 (06) ◽  
pp. 660-664
Author(s):  
Dileep Kumar ◽  
Awais Bashir Larik ◽  
Amir Shahzad

Objectives: To determine the in hospital mortality of convulsive status epilepticusin a tertiary care facility. Study Design: Cross sectional study. Place and Duration of Study:Neurology ward, Jinnah Postgraduate Medical Centre, Karachi, Medicine Department ofPeoples University Of Medical And Health Sciences Nawabshah from July 2015- Dec 2015.Material and Methods: All patients of either gender with age >15 years with status epilepticus,were included in the study. A detailed clinical history and relevant neurological examinationwas performed. All the patients who fulfill the inclusion criteria were enrolled in the study afterinformed written consent and explanation of the study protocol. All the information including inhospital mortality was entered on annexed proforma. All the patients were observed three to fivedays. Results: A total of 108 patients were included in this study fulfilling the inclusion criteria.The overall mean age of these patients was 31.3 ± 13.5 years. The age range of these patientswas 16 to 76 years. History of epilepsy was found in 106 (93.5%) of the patients, 88 (81.5%) ofthe patients had status epilepticus in past, 56 (51.9%) of the patients had drug withdrawal, 20(18.5%) of the patients had febrile illness and 2 (1.9%) of the patients had in hospital mortality.There was no statistical significance proportion difference was observed when comparedgender, history of epilepsy and status of epilepticus in past by in hospital mortality (p-values>0.05). Statistical significance proportion difference (p-value <0.05) was found in age and inhospital mortality. Conclusion: We recommend further studies to reach the firm conclusion.


2014 ◽  
Vol 3 (3) ◽  
pp. 153-59
Author(s):  
Maryam Poursadeghfard ◽  
Zabihollah Hashemzehi ◽  
Nahid Ashjazadeh

Background: Status epilepticus (SE) is one of the most common neurological emergencies with high mortality and morbidity. This study aims to determine the most common causes and outcomes of SE in adult patients from Fars Province in southern Iran. Materials and Methods: 134 patients with SE (either convulsive or non-convulsive), admitted to Namazi Hospital, were enrolled from January 2006 to February 2012. We designed a questionnaire to collect the patients' demographics and disease characteristics and their outcomes according to Glasgow Outcome Scale (GOS). Statistical analyses were performed using SPSS software version 15. P-value<0.05 was considered statistically significant. Results: Seventy patients were female and 64 were male with mean age of 42.97±19.66 years and 39.42±18.89 years old, respectively. Sixty-two patients (46.26%) had a history of epilepsy, and 72 patients (53.73%) had no history of epilepsy. Antiepileptic drugs (ADEs) withdrawal and cerebral infarction were the most common causes of SE in epileptics and non-epileptics, respectively. One hundred and twenty-three patients (91.8%) had generalized tonic-clonic SE. Thirty patients (22.4%) could return to work and 33 (24.6%) died during hospitalization. There was a significant relationship between mortality and age over 60 years (P<0.001), and mortality and cerebral infarction or anoxia (P= 0.022). Conclusion: ADEs withdrawal in the epileptic patients was the main cause of SE (28.40% of the total population and 62% of the epileptic patients) that can be prevented by patient and family education. This study showed that high mortality and morbidity were significantly related to the increasing age and etiology of SE.


Author(s):  
Pravin Taneja

Epilepsy is one of the most prevalent chronic neurological disorders both in the U.S. and worldwide, effecting ~1% of the world population. As a result, patients with a history of epilepsy frequently present for surgery. It is important to be aware of how to best characterize the severity of the disease, and treat seizures should they be encountered. In this chapter, we review the epidemiology and pathophysiology of epilepsy. We also discuss the most severe and life threatening form of the condition, status epilepticus. In this emergency situation it is critical that seizures be terminated, and supportive care given. We delineate initial treatment steps and medications, in addition to providing recommendations for refractory cases.


1993 ◽  
Vol 6 (6) ◽  
pp. 271-277
Author(s):  
Donna J. Schroeder ◽  
Brian K. Alldredge

Status epilepticus is a medical emergency that requires prompt intervention with effective anticonvulsant drug therapy to minimize the risk of morbidity and mortality. Although status epilepticus can occur as the first presentation of seizures, it is more common in patients who have a history of epilepsy. Metabolic disturbances, stroke, infection, and head trauma can also precipitate repetitive or continuous seizures and, if possible, the underlying etiology should be corrected as the first step in effective management. Permanent neurological sequelae are more likely as the duration of status epilepticus exceeds 90 minutes. In this regard, it is essential that anticonvulsant drug therapy is initiated as soon as possible. Benzodiazepines (diazepam, Iorazepam) are commonly used as the agents of choice for early termination of status epilepticus. Phenytoin and phenobarbital are also useful because of their long-lasting anticonvulsant effects. Other agents that may be useful under special circumstances include midazolam, fosphenytoin (phenytoin prodrug), sodium valproate, paraldehyde, and high-dose barbiturates.


Author(s):  
Michael J. Aminoff

AbstractThe pharmacologic management of major motor status epilepticus is summarized. When general anesthesia is required, the electroencephalogram (EEG) is used for monitoring the adequacy of treatment. The EEG findings may also be important in recognizing status epilepticus and monitoring its response to treatment when this is clinically difficult, as when it occurs in comatose or pharmacologically paralyzed patients or in the context of severe brain damage. Finally, the EEG helps to clarify the nature of motor activities of uncertain basis in patients in the intensive care unit and has indicated that non-convulsive seizures or status are more common than clinically suspected in such patients.


2021 ◽  
Vol 15 (3-4) ◽  
pp. 35-40
Author(s):  
V. M. Frolova ◽  
E. E. Kozharskaya

This article discusses the problem of school education as one of the aspects of social adaptation of children diagnosed with epilepsy and / or children with a history of status epilepticus. The authors provide statistical data on the prevalence of epilepsy among children of different ages and information on disease control. We collected the data of patients followed-up in Mytishchi Children’s Polyclinic No. 4. Using our own experience and publications of other authors, we have developed a number of recommendations that can potentially make the presence of a child with a history of epilepsy and / or status epilepticus in an educational institution more comfortable and safe. In particular, we have suggested creating an emergency plan for each child in case of seizures. This plan should be given to a healthcare professional working in the educational institution, as well as to teachers who are responsible for the life and health of the child during classes.


Sign in / Sign up

Export Citation Format

Share Document